Description

1H-Imidazo[4,5-C]Pyridine-2,4-Dione,1-Ethyl-3,5-Dihydro-3-Methyl-,4-Hydrazone(9Ci) is a specialized heterocyclic organic compound with a complex fused-ring structure, serving as a critical advanced pharmaceutical intermediate and research chemical. Its unique molecular architecture makes it a valuable building block for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated heterocyclic scaffolds. This high-purity compound is essential for medicinal chemistry research, process development, and the production of targeted drug candidates in the pharmaceutical and biotechnology industries.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates, especially those targeting central nervous system (CNS) disorders, oncology, and antiviral applications.
• Medicinal Chemistry & Drug Discovery: Used as a core scaffold or a derivatization starting point in high-throughput screening and structure-activity relationship (SAR) studies to develop new therapeutic agents.
• Biochemical Research: Employed in academic and industrial R&D to study enzyme inhibition, receptor binding, and other biological mechanisms due to its imidazopyridine-dione-hydrazone hybrid structure.
• Agrochemical Development: Potential intermediate for creating new crop protection agents, leveraging its heterocyclic system to develop novel fungicides or insecticides.
• Material Science Research: Investigated for its potential in creating organic electronic materials or metal-organic frameworks (MOFs) due to its nitrogen-rich, conjugated system capable of coordination.

Basic Information

Item	Details
Product Name	1H-Imidazo[4,5-C]Pyridine-2,4-Dione,1-Ethyl-3,5-Dihydro-3-Methyl-,4-Hydrazone(9Ci)
CAS No.	460739-76-8
Molecular Formula	C9H12N6O
Molecular Weight	220.23 g/mol
Synonyms	1-Ethyl-3,5-dihydro-3-methyl-1H-imidazo[4,5-c]pyridine-2,4-dione 4-hydrazone; 1-Ethyl-3-methyl-1,5-dihydro-4H-imidazo[4,5-c]pyridine-2,4-dione hydrazone; 460739-76-8; 1H-Imidazo[4,5-c]pyridine-2,4-dione, 1-ethyl-3,5-dihydro-3-methyl-, 4-hydrazone; 4-Hydrazono-1-ethyl-3-methyl-3,5-dihydro-1H-imidazo[4,5-c]pyridin-2-one
EINECS	Contact for details

Quality Control

Our production of 1H-Imidazo[4,5-C]Pyridine-2,4-Dione,1-Ethyl-3,5-Dihydro-3-Methyl-,4-Hydrazone(9Ci) adheres to stringent quality management protocols. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the exacting standards required for pharmaceutical R&D and intermediate synthesis. We provide detailed Certificates of Analysis (COA) with each shipment, documenting critical parameters such as assay, related substances, and residual solvents. Our quality systems are designed to support cGMP compliance for advanced intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its sensitivity to oxidation, long-term storage under an inert atmosphere (e.g., nitrogen or argon) is recommended for optimal stability. Keep away from heat, sparks, and open flame.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Loss on Drying	≤ 1.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.